The goal of this program is to improve pharmaceutical management of osteoporosis. After hearing and assimilating this program, the clinician will be better able to:Weigh the risks and benefits of common bisphosphonates on fracture risk and bone density.Estimate the risk for osteonecrosis of the jaw and atypical femur fracture in patients taking bisphosphonates for osteoporosis.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Obstetrics-and-Gynecology
- Start Date: 2024-09-26 05:00:00
- End Date: 2024-09-26 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest